 |
|
Comparison of effectiveness of growth hormone therapy according to disease-causing genes in children with Noonan syndrome
Kyo Jin Jo (Jo KJ), Yoo Mi Kim (Kim YM), Ju Young Yoon (Yoon JY), Yeoun Joo Lee (Lee YJ), Young Mi Han (Han YM), Han-Wook Yoo (Yoo HW), Hyang-Sook Kim (Kim HS), Chong Kun Cheon (Cheon CK)
Clin Exp Pediatr. 2019;62(7):274-280. Published online 2018 Dec 3 DOI: https://doi.org/10.3345/kjp.2018.06842
|
|
Citations to this article as recorded by
 Near Adult Height and Body Mass Index Changes in Growth Hormone Treated Short Children with Noonan Syndrome: The Belgian Experience
Jean De Schepper, Muriel Thomas, Koen Huysentruyt, Marianne Becker, Emese Boros, Kristina Casteels, Olimpia Chivu, Kathleen De Waele, Hilde Dotremont, Philippe A. Lysy, Guy Massa, Anne-Simone Parent, Anne Rochtus, Inge Gies
Hormone Research in Paediatrics.2024; : 1. CrossRef Efficacy of cibenzoline for hypertrophic obstructive cardiomyopathy in paediatric patients with RAS/MAPK pathway syndromes
Kota Watanabe, Yuji Maruo, Atsuhito Takeda
Cardiology in the Young.2023; 33(6): 1007. CrossRef Cardiovascular Characteristics and Progressions of Hypertrophic Cardiomyopathy and Pulmonary Stenosis in RASopathy Syndrome in the Genomic Era
Susan Taejung Kim, Sang Yun Lee, Gi Beom Kim, Eun Jung Bae, Jung Min Ko, Mi Kyoung Song
The Journal of Pediatrics.2023; 262: 113351. CrossRef Efficacy and safety of growth hormone therapy in children with Noonan syndrome
Giorgio Sodero, Clelia Cipolla, Lucia Celeste Pane, Linda Sessa, Elena Malavolta, Federica Arzilli, Chiara Leoni, Giuseppe Zampino, Donato Rigante
Growth Hormone & IGF Research.2023; 69-70: 101532. CrossRef Inside the Noonan “universe”: Literature review on growth, GH/IGF axis and rhGH treatment: Facts and concerns
Stefano Stagi, Vittorio Ferrari, Marta Ferrari, Manuela Priolo, Marco Tartaglia
Frontiers in Endocrinology.2022;[Epub] CrossRef Outcomes in growth hormone-treated Noonan syndrome children: impact of PTPN11 mutation status
Alexander A L Jorge, Thomas Edouard, Mohamad Maghnie, Alberto Pietropoli, Nicky Kelepouris, Alicia Romano, Martin Zenker, Reiko Horikawa
Endocrine Connections.2022;[Epub] CrossRef Genetic conditions of short stature: A review of three classic examples
Merlin G. Butler, Bradley S. Miller, Alicia Romano, Judith Ross, M. Jennifer Abuzzahab, Philippe Backeljauw, Vaneeta Bamba, Amrit Bhangoo, Nelly Mauras, Mitchell Geffner
Frontiers in Endocrinology.2022;[Epub] CrossRef Noonan syndrome patients with short stature at a single paediatric endocrinology centre
Yana Deyanova, Violeta Iotova, Milena Stoyanova, Irina Halvadzhiyan, Rositsa Stoicheva, Kaloyan Tsochev, Vilhelm Mladenov, Yuliya Bazdarska, Nikolinka Yordanova, Sonya Galcheva, Vesselin Boyadzhiev, Martin Zenker
Scripta Scientifica Medica.2022; 54(3): 21. CrossRef Activation of the MAPK pathway (RASopathies) and partial growth hormone insensitivity
Alexsandra C. Malaquias, Alexander A.L. Jorge
Molecular and Cellular Endocrinology.2021; 519: 111040. CrossRef Growth in Children With Noonan Syndrome and Effects of Growth Hormone Treatment on Adult Height
Annachiara Libraro, Vito D’Ascanio, Marco Cappa, Mariangela Chiarito, Maria Cristina Digilio, Silvia Einaudi, Anna Grandone, Mohamad Maghnie, Laura Mazzanti, Alessandro Mussa, Giuseppa Patti, Emanuela Scarano, Antonietta Spinuzza, Silvia Vannelli, Malgorz
Frontiers in Endocrinology.2021;[Epub] CrossRef Effectiveness of growth hormone therapy in children with Noonan syndrome
Eun mi Seok, Hong Kyu Park, Jung Gi Rho, Change Dae Kum, Hae Sang Lee, Jin Soon Hwang
Annals of Pediatric Endocrinology & Metabolism.2020; 25(3): 182. CrossRef Correlation between genetic heterogeneity and variability for response to growth hormone in Noonan syndrome
Young-Lim Shin
Korean Journal of Pediatrics.2019; 62(11): 412. CrossRef
|